Covid-19: WHO resumes study of Hydroxychloroquine
There is great news about hydroxychloroquine. The World Health Organization has called for the resumption of the coronavirus trial
There is great news about hydroxychloroquine. The World Health Organization has called for the resumption of the coronavirus trial of hydroxychloroquine.
The WHO tweeted about it on Wednesday. The WHO recently issued a directive to member states that hydroxychloroquine could be dangerous in treating the corona virus. Therefore, stop its trial.
Recently, the WHO issued a directive to members that hydroxychloroquine may be dangerous in the treatment of corona virus. So, stop it but Indian scientists have not only discovered this drug but also told the doctors of the country that this drug can be avoided in the treatment of corona virus.
Subsequently, India launched a front against the WHO in the fight against the corona virus epidemic. Research and treatment will do what is necessary in the interest of the country. At the same time, it has made it clear to Indian scientists that they do not need the WHO's advice.
If this cheap drug is used to protect against the corona virus, Western pharmaceutical companies could lose crores of rupees. That is why their lobby wanted to put pressure on the WHO to stop all trials of hydroxychloroquine.